Axcella

About:

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

Website: https://axcellatx.com

Top Investors: Fidelity, Flagship Pioneering, Nestlé Health Science, Enso Ventures, Rajiv Kaul

Description:

Axcella is a clinical-stage biotechnology company that treats complex diseases using endogenous metabolic modulator (EMM) compositions. They combine biological pathways with developments in systems biology and machine learning. Their proprietary platform is clinically validated across several indication areas, with clinical-stage candidates in muscle, neurodegenerative, and liver conditions.